Abstract
An elderly male presented with complaints of decrease in vision in the left eye since 1 week. He had a recurrent submacular hemorrhage secondary to polypoidal choroidal vasculopathy (PCV) and was treated with intravitreal brolucizumab. There was complete resolution of subretinal fluid and improvement in visual acuity to 20/20 on follow-up. Indocyanine green angiography at 1 year showed complete regression of polypoidal lesions. This case report highlights the role of brolucizumab as an effective treatment option in resistant PCV and its role in regression of polypoidal lesions in PCV.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
